Form 4 for HCWB HCW Biologics Inc.
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0001209191-24-003782 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-20 | HCWB | Byam Rebecca | CFO | A - Grant | $1.40 | +760.7K | 1.38M | +122% | +$1.06M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | A | A | 760,714 | $1.40 | 1,381,909 | D | — | — |